20MP Stock Overview
Through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Mountain Valley MD Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.013 |
| 52 Week High | CA$0.044 |
| 52 Week Low | CA$0.0002 |
| Beta | 0.89 |
| 11 Month Change | 8.33% |
| 3 Month Change | 8.33% |
| 1 Year Change | -16.67% |
| 33 Year Change | -90.97% |
| 5 Year Change | n/a |
| Change since IPO | -83.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 20MP | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 400.0% | -2.7% | 0.1% |
| 1Y | -16.7% | -6.6% | 19.6% |
Return vs Industry: 20MP underperformed the German Pharmaceuticals industry which returned -6.6% over the past year.
Return vs Market: 20MP underperformed the German Market which returned 19.6% over the past year.
Price Volatility
| 20MP volatility | |
|---|---|
| 20MP Average Weekly Movement | 181.5% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 20MP's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 20MP's weekly volatility has decreased from 1185% to 183% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Dennis Hancock | www.mountainvalleymd.com |
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company in Canada. The company offers Quicksome oral drug formulation and delivery technologies; and Quicksol solubility formulation and delivery technology. It also provides licensed Agrarius, an agricultural plant signalling technology; and solubilized drugs to husbandry animal health.
Mountain Valley MD Holdings Inc. Fundamentals Summary
| 20MP fundamental statistics | |
|---|---|
| Market cap | €7.02m |
| Earnings (TTM) | -€5.09m |
| Revenue (TTM) | €58.48k |
120.1x
P/S Ratio-1.4x
P/E RatioIs 20MP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 20MP income statement (TTM) | |
|---|---|
| Revenue | CA$88.00k |
| Cost of Revenue | CA$406.00k |
| Gross Profit | -CA$318.00k |
| Other Expenses | CA$7.34m |
| Earnings | -CA$7.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.022 |
| Gross Margin | -361.36% |
| Net Profit Margin | -8,700.00% |
| Debt/Equity Ratio | 0% |
How did 20MP perform over the long term?
See historical performance and comparison